HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 102.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424,642 | -42.6% | 98,754 | -26.7% | 0.00% | -66.7% |
| Q2 2023 | $739,228 | +183.2% | 134,650 | +116.6% | 0.00% | +200.0% |
| Q1 2023 | $261,034 | +358.0% | 62,151 | +177.7% | 0.00% | – |
| Q3 2022 | $57,000 | -64.4% | 22,377 | -49.8% | 0.00% | -100.0% |
| Q2 2022 | $160,000 | -15.8% | 44,582 | +45.4% | 0.00% | 0.0% |
| Q1 2022 | $190,000 | -78.6% | 30,653 | -75.6% | 0.00% | -66.7% |
| Q4 2021 | $886,000 | +129.5% | 125,640 | +127.0% | 0.00% | +200.0% |
| Q3 2021 | $386,000 | -46.8% | 55,356 | -76.3% | 0.00% | -80.0% |
| Q2 2020 | $725,000 | -46.5% | 234,000 | -46.9% | 0.01% | -44.4% |
| Q3 2019 | $1,354,000 | +5107.7% | 440,346 | +3295.9% | 0.01% | – |
| Q2 2019 | $26,000 | -92.7% | 12,967 | -84.3% | 0.00% | -100.0% |
| Q1 2019 | $357,000 | – | 82,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |